185 related articles for article (PubMed ID: 34285285)
1. MiR-486-3p was downregulated at microRNA profiling of adrenals of multiple endocrine neoplasia type 1 mice, and inhibited human adrenocortical carcinoma cell lines.
Li SC; Monazzam A; Razmara M; Chu X; Stålberg P; Skogseid B
Sci Rep; 2021 Jul; 11(1):14772. PubMed ID: 34285285
[TBL] [Abstract][Full Text] [Related]
2. The role of microRNA deregulation in the pathogenesis of adrenocortical carcinoma.
Özata DM; Caramuta S; Velázquez-Fernández D; Akçakaya P; Xie H; Höög A; Zedenius J; Bäckdahl M; Larsson C; Lui WO
Endocr Relat Cancer; 2011 Oct; 18(6):643-55. PubMed ID: 21859927
[TBL] [Abstract][Full Text] [Related]
3. MEN1 and microRNAs: The link between sporadic pituitary, parathyroid and adrenocortical tumors?
Nagy Z; Szabó PM; Grolmusz VK; Perge P; Igaz I; Patócs A; Igaz P
Med Hypotheses; 2017 Feb; 99():40-44. PubMed ID: 28110695
[TBL] [Abstract][Full Text] [Related]
4. MicroRNA-142-3p, a novel target of tumor suppressor menin, inhibits osteosarcoma cell proliferation by down-regulation of FASN.
Yang YQ; Qi J; Xu JQ; Hao P
Tumour Biol; 2014 Oct; 35(10):10287-93. PubMed ID: 25034529
[TBL] [Abstract][Full Text] [Related]
5. Differential expression of microRNA-675, microRNA-139-3p and microRNA-335 in benign and malignant adrenocortical tumours.
Schmitz KJ; Helwig J; Bertram S; Sheu SY; Suttorp AC; Seggewiss J; Willscher E; Walz MK; Worm K; Schmid KW
J Clin Pathol; 2011 Jun; 64(6):529-35. PubMed ID: 21471143
[TBL] [Abstract][Full Text] [Related]
6. MiR-193a-3p functions as a tumour suppressor in human aldosterone-producing adrenocortical adenoma by down-regulating CYP11B2.
Zhang G; Zou X; Liu Q; Xie T; Huang R; Kang H; Lai C; Zhu J
Int J Exp Pathol; 2018 Apr; 99(2):77-86. PubMed ID: 29665181
[TBL] [Abstract][Full Text] [Related]
7. Analysis of circulating extracellular vesicle-associated microRNAs in cortisol-producing adrenocortical tumors.
Perge P; Decmann Á; Pezzani R; Bancos I; Fassina A; Luconi M; Canu L; Tóth M; Boscaro M; Patócs A; Igaz P
Endocrine; 2018 Feb; 59(2):280-287. PubMed ID: 29299796
[TBL] [Abstract][Full Text] [Related]
8. Multiple endocrine neoplasia type 1 gene expression is normal in sporadic adrenocortical tumors.
Zwermann O; Beuschlein F; Mora P; Weber G; Allolio B; Reincke M
Eur J Endocrinol; 2000 Jun; 142(6):689-95. PubMed ID: 10822234
[TBL] [Abstract][Full Text] [Related]
9. Bilateral adrenocortical carcinoma in a patient with multiple endocrine neoplasia type 1 (MEN1) and a novel mutation in the MEN1 gene.
Griniatsos JE; Dimitriou N; Zilos A; Sakellariou S; Evangelou K; Kamakari S; Korkolopoulou P; Kaltsas G
World J Surg Oncol; 2011 Jan; 9():6. PubMed ID: 21266030
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA expression patterns in adrenocortical carcinoma variants and clinical pathologic correlations.
Duregon E; Rapa I; Votta A; Giorcelli J; Daffara F; Terzolo M; Scagliotti GV; Volante M; Papotti M
Hum Pathol; 2014 Aug; 45(8):1555-62. PubMed ID: 24890943
[TBL] [Abstract][Full Text] [Related]
11. Proliferation rates of multiple endocrine neoplasia type 1 (MEN1)-associated tumors.
Walls GV; Reed AA; Jeyabalan J; Javid M; Hill NR; Harding B; Thakker RV
Endocrinology; 2012 Nov; 153(11):5167-79. PubMed ID: 23024266
[TBL] [Abstract][Full Text] [Related]
12. Multi-genomic analysis of 260 adrenocortical cancer patient tumors identifies novel network BIRC5-hsa-miR-335-5p-PAX8-AS1 strongly associated with poor survival.
Subramanian C; McCallister R; Cohen MS
Surgery; 2023 Jan; 173(1):43-51. PubMed ID: 36202651
[TBL] [Abstract][Full Text] [Related]
13. microRNA-431 as a Chemosensitizer and Potentiator of Drug Activity in Adrenocortical Carcinoma.
Kwok GTY; Zhao JT; Glover AR; Gill AJ; Clifton-Bligh R; Robinson BG; Ip JCY; Sidhu SB
Oncologist; 2019 Jun; 24(6):e241-e250. PubMed ID: 30918109
[TBL] [Abstract][Full Text] [Related]
14. A new mutation in the menin gene causes the multiple endocrine neoplasia type 1 syndrome with adrenocortical carcinoma.
Haase M; Anlauf M; Schott M; Schinner S; Kaminsky E; Scherbaum WA; Willenberg HS
Endocrine; 2011 Apr; 39(2):153-9. PubMed ID: 21069576
[TBL] [Abstract][Full Text] [Related]
15. Integrated genome-wide analysis of genomic changes and gene regulation in human adrenocortical tissue samples.
Gara SK; Wang Y; Patel D; Liu-Chittenden Y; Jain M; Boufraqech M; Zhang L; Meltzer PS; Kebebew E
Nucleic Acids Res; 2015 Oct; 43(19):9327-39. PubMed ID: 26446994
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA signature in massive macronodular adrenocortical disease and implications for adrenocortical tumourigenesis.
Bimpaki EI; Iliopoulos D; Moraitis A; Stratakis CA
Clin Endocrinol (Oxf); 2010 Jun; 72(6):744-51. PubMed ID: 19849700
[TBL] [Abstract][Full Text] [Related]
17. Integrative molecular bioinformatics study of human adrenocortical tumors: microRNA, tissue-specific target prediction, and pathway analysis.
Tömböl Z; Szabó PM; Molnár V; Wiener Z; Tölgyesi G; Horányi J; Riesz P; Reismann P; Patócs A; Likó I; Gaillard RC; Falus A; Rácz K; Igaz P
Endocr Relat Cancer; 2009 Sep; 16(3):895-906. PubMed ID: 19546168
[TBL] [Abstract][Full Text] [Related]
18. Fatty acid synthase is a primary target of MiR-15a and MiR-16-1 in breast cancer.
Wang J; Zhang X; Shi J; Cao P; Wan M; Zhang Q; Wang Y; Kridel SJ; Liu W; Xu J; Zhang Q; Sui G
Oncotarget; 2016 Nov; 7(48):78566-78576. PubMed ID: 27713175
[TBL] [Abstract][Full Text] [Related]
19. Adrenocortical tumors have a distinct, long, non-coding RNA expression profile and LINC00271 is downregulated in malignancy.
Buishand FO; Liu-Chittenden Y; Fan Y; Tirosh A; Gara SK; Patel D; Meerzaman D; Kebebew E
Surgery; 2020 Jan; 167(1):224-232. PubMed ID: 31522749
[TBL] [Abstract][Full Text] [Related]
20. Characterization of differential gene expression in adrenocortical tumors harboring beta-catenin (CTNNB1) mutations.
Durand J; Lampron A; Mazzuco TL; Chapman A; Bourdeau I
J Clin Endocrinol Metab; 2011 Jul; 96(7):E1206-11. PubMed ID: 21565795
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
